Research study Program year 2020 Source: CMS Open Payments

M16-098

ClinicalTrials.gov NCT03178487

Research payments

$556,661

151 payments

Through program year 2020, $556,661 in research payments was reported against M16-098, across 151 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03178487

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$282,442	53
2019	Research	$274,220	98

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $556,661 151 payments

Who received the money Research payments · program years 2019–2020

Bay Area Arthritis And Osteoporosis Organisation paid for research $175,098 18 payments
Clinical Investigation Specialists, Inc. Organisation paid for research $66,743 13 payments
Djl Clinical Research Pllc Organisation paid for research $54,289 20 payments
St Joseph Heritage Healthcare Organisation paid for research $44,830 15 payments
Clinical Investigation Specialists INC Organisation paid for research $38,834 9 payments
The Osteoporosis Medical Center Organisation paid for research $27,113 8 payments
Vipul Joshi, MD PA Organisation paid for research $24,983 8 payments
Arizona Arthritis and Rheumatology Associates Organisation paid for research $21,911 14 payments
Aa Mrc LLC Organisation paid for research $18,817 9 payments
Scientia Medical Research Organisation paid for research $18,221 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.